First Stage Investor

Q&A With 20/20 GeneSystems

Q&A With 20/20 GeneSystems
By Andy Gordon
Date February 15, 2018
Share
Today, we’re bringing you a fascinating conversation we had with Jonathan Cohen, the founder and CEO of our recently recommended company 20/20 GeneSystems. 20/20 focuses on reducing cancer mortality worldwide through early detection. It has pioneered a novel approach of continuous machine learning using large data sets…
Early Investing

First Stage Investor

Sign up to view this First Stage Investor article

Become a smarter investor! Discover new investment opportunities and get the latest market research, trends and analysis in startups, crypto and cannabis.

Sign up today

Top Posts on Early Investing

Crypto Monitor: A Victory for Crypto in China and Hong Kong

China has a complicated relationship with crypto. The Chinese government continues to promote the use and development of blockchain, but crypto trading is still banned in mainland China.…

Bitcoin Decouples From Stocks, Moves Closer to Gold

Crypto Market Musings It’s been a relatively calm week for crypto. Bitcoin is up 1.73% over the last seven days as of this writing. Ethereum is up 3.54%…

New Pick: A Hidden Treasure in the Plant-Based Meat Market

Editor’s Note: This recommendation was co-authored by KingsCrowd Investment Research Manager Olivia Strobl. Mmmm, pizza.